These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36727044)

  • 21. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ductal carcinoma in situ on digital mammography versus digital breast tomosynthesis: rates and predictors of pathologic upgrade.
    Kim G; Mikhael PG; Oseni TO; Bahl M
    Eur Radiol; 2020 Nov; 30(11):6089-6098. PubMed ID: 32591884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.
    van Ravesteyn NT; Stout NK; Schechter CB; Heijnsdijk EA; Alagoz O; Trentham-Dietz A; Mandelblatt JS; de Koning HJ
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25948872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of three decades of screening mammography on breast-cancer incidence.
    Bleyer A; Welch HG
    N Engl J Med; 2012 Nov; 367(21):1998-2005. PubMed ID: 23171096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of ductal carcinoma in situ (DCIS).
    Virnig BA; Shamliyan T; Tuttle TM; Kane RL; Wilt TJ
    Evid Rep Technol Assess (Full Rep); 2009 Sep; (185):1-549. PubMed ID: 20629475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
    Théberge I; Vandal N; Guertin MH; Perron L
    Breast Cancer Res Treat; 2019 Apr; 174(2):525-535. PubMed ID: 30564969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112).
    Fazeli S; Snyder BS; Gareen IF; Lehman CD; Khan SA; Romanoff J; Gatsonis CA; Miller KD; Sparano JA; Comstock CE; Wagner LI; Carlos RC
    JAMA Netw Open; 2021 Nov; 4(11):e2129697. PubMed ID: 34726748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients.
    Gregorowitsch ML; van den Bongard HJGD; Young-Afat DA; Pignol JP; van Gils CH; May AM; Verkooijen HM
    Breast Cancer Res Treat; 2018 Jan; 167(1):205-213. PubMed ID: 28894982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program.
    Ernster VL; Barclay J; Kerlikowske K; Wilkie H; Ballard-Barbash R
    Arch Intern Med; 2000 Apr; 160(7):953-8. PubMed ID: 10761960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Home-based multidimensional survivorship programmes for breast cancer survivors.
    Cheng KKF; Lim YTE; Koh ZM; Tam WWS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
    Comstock CE; Gatsonis C; Newstead GM; Snyder BS; Gareen IF; Bergin JT; Rahbar H; Sung JS; Jacobs C; Harvey JA; Nicholson MH; Ward RC; Holt J; Prather A; Miller KD; Schnall MD; Kuhl CK
    JAMA; 2020 Feb; 323(8):746-756. PubMed ID: 32096852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
    Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
    Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age.
    Evans WP; Starr AL; Bennos ES
    Radiology; 1997 Aug; 204(2):489-91. PubMed ID: 9240541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overdiagnosis among women attending a population-based mammography screening program.
    Falk RS; Hofvind S; Skaane P; Haldorsen T
    Int J Cancer; 2013 Aug; 133(3):705-12. PubMed ID: 23355313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ.
    Bluman LG; Borstelmann NA; Rimer BK; Iglehart JD; Winer EP
    J Womens Health Gend Based Med; 2001; 10(6):589-98. PubMed ID: 11559456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data.
    Weedon-Fekjær H; Li X; Lee S
    J Med Screen; 2021 Sep; 28(3):302-310. PubMed ID: 32854582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease.
    Kwong A; Hancock SL; Bloom JR; Pal S; Birdwell RL; Mariscal C; Ikeda DM
    Breast J; 2008; 14(1):39-48. PubMed ID: 18186864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.